A. Seaton

发表

Asbestos: scientific developments and implications for public policy.

A. Seaton, B. Mossman, J. Bignon, 1990, Science.

Diabetic foot infection: Antibiotic therapy and good practice recommendations

G. Leese, M. Young, S. Dancer, 2017, International journal of clinical practice.

Widow's attempt to use her dead husband's sperm

E. Simons, A. Seaton, K. Ahuja, 1997, BMJ.

Egg-sharing in assisted conception: ethical and practical considerations.

E. Simons, A. Seaton, S. Sharp, 1996, Human reproduction.

A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications

B. Godman, A. Seaton, A. Kurdi, 2021, Expert review of anti-infective therapy.

Wound botulism presenting as dysphagia to an ENT ward

A. Seaton, L. Q. Li, A. Cadamy, 2020, BMJ Case Reports.

Oral versus Intravenous Antibiotics for Bone and Joint Infection

A. Briggs, Benjamin A Lipsky, Michelle Kümin, 2019, The New England journal of medicine.

Pregnancy following intracytoplasmic sperm injection treatment with dead husband's spermatozoa: ethical and policy considerations.

E. Simons, A. Seaton, K. Ahuja, 1997, Human Reproduction.

Helminth injections of dogs in central Texas.

A. Seaton, J. Smith, 1981, Veterinary medicine, small animal clinician : VM, SAC.

Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial

A. Briggs, Benjamin A Lipsky, A. Walker, 2015, Trials.

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Scott M Elliott, J. Haughney, V. Libri, 2021, The Lancet.

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

J. Haughney, V. Libri, M. Kamal, 2022, The Lancet Infectious Diseases.

Co-Infections, Secondary Infections, and Antimicrobial Usage in Hospitalised Patients with COVID-19 from the ISARIC WHO CCP-UK Study: A Prospective, Multicentre Cohort Study

J. Nguyen-Van-Tam, L. Merson, J. Dunning, 2021, SSRN Electronic Journal.

Use of antibiotics in people with diabetic foot disease: A consensus statement

W. Jeffcoate, Benjamin A Lipsky, D. Nathwani, 2009 .

Immunological findings in African patients with pulmonary tuberculosis and HIV-2 infection.

H. Whittle, A. Seaton, T. Corrah, 1992, AIDS (London).

Ultrasonic monitoring during replacement of frozen/thawed embryos in natural and hormone replacement cycles.

A. Seaton, I. Craft, T. Al‐Shawaf, 1993, Human reproduction.

Meningococcal meningitis and COVID-19 co-infection

A. Seaton, S. Gallacher, 2020, BMJ Case Reports.

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

A. Seaton, R. Seaton, K. Hamed, 2016, Infection and drug resistance.

Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship

B. Godman, A. Seaton, R. Seaton, 2019, JAC-antimicrobial resistance.

Key issues in the development of a non‐inpatient intravenous (NIPIV) antibiotic therapy programme - a European perspective

D. Nathwani, P. Davey, A. Seaton, 1997 .